RYACTLA

Trademark usage description

pharmaceutical products for the treatment of cancer.

Classification Information

2327439

Trademark

Action Taken	Status
Submitted for opposition 42 on 9^th Apr 2025	Advertised
Submitted for opposition 256 on 17^th Mar 2025	Notification of Possible Opposition Sent
Submitted for opposition 27 on 13^th Mar 2025	Approval Notice Sent
Submitted for opposition 26 on 13^th Mar 2025	Approved
Submitted for opposition 22 on 5^th Mar 2025	Search Recorded
Submitted for opposition 257 on 16^th May 2024	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 15^th May 2024	Formalized
Submitted for opposition 1 on 15^th May 2024	Created
Submitted for opposition 30 on 26^th Feb 2024	Filed
Submitted for opposition 228 on 26^th Feb 2024	International Registration

Manage cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.